APA (7th ed.) Citation

Hoveidaei, A. H., Ghaseminejad-Raeini, A., Hosseini-Asl, S. H., Shrestha, A., Hoveidaei, A., Taghavi, S. P., . . . Conway, J. D. (2024). Initiating chemotherapy in joint arthroplasty patients increases the risk of periprosthetic joint infections. Archives of Orthopaedic & Trauma Surgery, 144(12), 5147. https://doi.org/10.1007/s00402-024-05307-4

Chicago Style (17th ed.) Citation

Hoveidaei, Amir Human, Amirhossein Ghaseminejad-Raeini, Seyed Hossein Hosseini-Asl, Ashesh Shrestha, Armin Hoveidaei, Seyed Pouya Taghavi, Basilia Onyinyechukwu Nwankwo, Mohammad Saeid Khonji, and Janet D. Conway. "Initiating Chemotherapy in Joint Arthroplasty Patients Increases the Risk of Periprosthetic Joint Infections." Archives of Orthopaedic & Trauma Surgery 144, no. 12 (2024): 5147. https://doi.org/10.1007/s00402-024-05307-4.

MLA (9th ed.) Citation

Hoveidaei, Amir Human, et al. "Initiating Chemotherapy in Joint Arthroplasty Patients Increases the Risk of Periprosthetic Joint Infections." Archives of Orthopaedic & Trauma Surgery, vol. 144, no. 12, 2024, p. 5147, https://doi.org/10.1007/s00402-024-05307-4.